Neuromol 500mg/5mg Tablet

Introduction

Neuromol is a prescription medication that combines two active ingredients: Paracetamol and Prochlorperazine. Paracetamol is a commonly used pain reliever and fever reducer, while Prochlorperazine is an antipsychotic medication that also helps relieve nausea and vomiting. Neuromol is primarily used to treat headaches, migraines, and symptoms of nausea and vomiting associated with various conditions.

Uses

Neuromol is prescribed to manage the following conditions:

• Headaches: It can help alleviate mild to moderate headaches, including tension headaches and migraines.
• Nausea and Vomiting: Neuromol can be used to relieve symptoms of nausea and vomiting caused by various factors, such as migraines, motion sickness, and certain medical procedures.

Dosage and Administration

follow the dosage instructions provided by your healthcare professional or as indicated on the product label. The usual recommended dosage for adults is one tablet taken orally every 4 to 6 hours as needed for pain relief or relief of nausea and vomiting. Do not exceed the maximum daily dose of 8 tablets.

Mechanism of Action

Paracetamol works by inhibiting the production of certain chemicals in the body called prostaglandins, which are responsible for pain and fever. This helps to reduce pain and lower body temperature. Prochlorperazine, on the other hand, acts on certain receptors in the brain, including dopamine receptors, to help relieve nausea and vomiting.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, and constipation. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as rapid heartbeat, difficulty breathing, or unusual muscle movements, seek medical attention immediately.

Drug Interactions

Neuromol may interact with certain medications, including:

• Central Nervous System (CNS) depressants: Combining Neuromol with other medications that have sedative effects, such as alcohol, opioids, or other central nervous system depressants, may increase the risk of drowsiness and respiratory depression.
• Monoamine oxidase inhibitors (MAOIs): Concurrent use of Neuromol with MAOIs or within 14 days of discontinuing MAOIs may increase the risk of serious side effects.

Inform your healthcare professional about all the medications you are currently taking to avoid potential drug interactions.

Precautions

Before taking Neuromol, inform your healthcare professional if you have any of the following conditions:

• Liver or kidney disease
• Glaucoma
• Prostate enlargement
• Blood disorders

Neuromol may not be suitable for individuals with these conditions or may require dosage adjustments. Avoid alcohol while taking this medication, as it may increase the risk of side effects.

Storage

Patient Tips

• Take Neuromol exactly as prescribed by your healthcare professional. Do not exceed the recommended dosage or use it for longer than advised.
• If you experience persistent or worsening symptoms, consult your healthcare professional.
• Avoid activities that require alertness, such as driving or operating machinery, if you feel drowsy or dizzy after taking Neuromol.
• If you are pregnant, planning to become pregnant, or breastfeeding, discuss with your healthcare professional before using this medication.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Paracetamol for adults: painkiller for pain and high temperature (NHS UK) [Accessed 17 Jun. 2024] (online) Available at:
• Alka-Seltzer XS (Health Professionals SmPC) Available at:
• Paracetamol (Drugs.com) [Accessed 18 Jun. 2024] (online) Available at:
• paracetamol tablet (OTC) [Accessed 9 Jun. 2024] (online) Available at:
• Acetaminophen Level: MedlinePlus Medical Test (MedlinePlus) [Accessed 23 Jun. 2024] (online) Available at: acetaminophen-level” rel=”noreferrer noopener” target=”_blank”>
• Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014 Jan-Feb;71(1):11-23. [Accessed 27 Jun. 2024] Available at: